$2200 | SAVE $300 | Single User
$4400 | SAVE $600 | Site License
$6600 | SAVE $900 | Enterprise License

Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017
[Report Updated: 11-08-2017]

Published by Global Data: 11 Aug 2017 | 119687 | In Stock
Related Topics: Clinical Trials

Introduction

Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, “Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017" provides an overview of Elephantiasis (Lymphatic Filariasis) clinical trials scenario. This report provides top line data relating to the clinical trials on Elephantiasis (Lymphatic Filariasis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017 [Report Updated: 11-08-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials by E7 Countries: Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials 28

    Prominent Drugs 29

    Clinical Trial Profile Snapshots 30

    Appendix 48

    Abbreviations 48

    Definitions 48

    Research Methodology 49

    Secondary Research 49

    About GlobalData 50

    Contact Us 50

    Source 50

List Of Tables
in Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017 [Report Updated: 11-08-2017]

List of Tables

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Region, 2017* 7

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Europe, Top Countries, 2017* 12

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15

Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16

Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17

Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18

Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Phase, 2017* 21

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Elephantiasis (Lymphatic Filariasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List Of Figures, Charts and Diagrams
in Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017 [Report Updated: 11-08-2017]

List of Figures

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14

Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16

Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17

Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18

Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22

Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Elephantiasis (Lymphatic Filariasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

GlobalData Methodology 49

Additional Details

Publisher

Global Data

Publisher Information

Reference

119687 | GDHC4425CTIDB

Number of Pages

50

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2019
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest...
30 Aug 2019 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Elephantiasis- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Elephantiasis- Market Insights, Epidemiology and Market Forecast 2028" report provide...
26 Jul 2019 by MIReports USD $5,262 (normally
USD $5,980)
More Info
SAVE 12% today! 2019 Elephantiasis (Lymphatic Filariasis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Elephantiasis (Lymphatic Filariasis) Clinical Trials Study” ...
24 Apr 2019 by VPA Research USD $1,583 (normally
USD $1,799)
More Info
SAVE 12% today! Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2018
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest...
17 Jul 2018 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2017
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest...
18 Jul 2017 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2017
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest...
28 Feb 2017 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015
Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015SummaryGlobalData's clin...
30 Oct 2015 by Global Data USD $2,200 (normally
USD $2,500)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2017 [Report Updated: 11-08-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...